Clinical Trials Logo

Macular Edema, Diabetic clinical trials

View clinical trials related to Macular Edema, Diabetic.

Filter by:
  • None
  • Page 1

NCT ID: NCT02788877 Active, not recruiting - Clinical trials for Macular Edema, Diabetic

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)

VIBIM
Start date: April 10, 2016
Phase: Phase 4
Study type: Interventional

Efficacy of Treat-and-extend regimen (TER) using aflibercept in diabetic macular edema (DME) will be evaluated.

NCT ID: NCT01994291 Terminated - Clinical trials for Macular Edema, Diabetic

A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema

Start date: November 2013
Phase: Phase 2
Study type: Interventional

The study hypothesis under test is that administration of the CCR2/5 antagonist has the potential to be as effective as the current treatment options for subjects with diabetic macular edema. The current treatment option for these subjects is an injection directly into the eye, while this CCR2/5 antagonist would be an oral drug which has the potential to be just as effective. This CCR2/5 antagonist also has a broader anti-inflammatory potential and might be able to provide an alternative mechanism to treat Diabetic Macular Edema.